Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
diagnostics
2
×
hepatitis b
indiana blog main
indiana top stories
life sciences
merck
microbiome
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
accent therapeutics
What
bio
drug
2
×
roundup
acquisitions
advantages
bar
biggest
brings
build
buy
ceo
company’s
daniel
debut
dyne’s
expect
gamble
gilead
market
medco’s
microbiome
mover
moves
new
openly
o’day
patients
payers
physicians
pipeline
plan
pricing
sciences
scores
seagen
sets
spoken
type
ubiome
undone
Language
unset
2
×
Current search:
diagnostics
×
drug
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
